Anika Therapeutics, Inc. Finance Lease, Liability, Undiscounted Excess Amount
Anika Therapeutics, Inc. (ANIK) had Finance Lease, Liability, Undiscounted Excess Amount of $2.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2022-08-04
- 2022-06-30: Finance Lease, Liability, Undiscounted Excess Amount $2.00K.
- 2021-12-31: Finance Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2020-12-31: Finance Lease, Liability, Undiscounted Excess Amount $32.00K.
- 2020-09-30: Finance Lease, Liability, Undiscounted Excess Amount $44.00K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-06-30 | $2.00K 10-Q · filed 2022-08-04 |
| 2021-12-31 | $14.00K 10-K · filed 2022-03-11 |
| 2020-12-31 | $32.00K 10-K/A · filed 2021-04-26 |
| 2020-09-30 | $44.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $57.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $66.00K 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |